This article develops and analyzes patient register-based measures of quality for the major Nordic countries. Previous studies show that Finnish hospitals have significantly higher average productivity than hospitals in Sweden, Denmark, and Norway and also a substantial variation within each country. This paper examines whether quality differences can form part of the explanation and attempts to uncover quality-cost trade-offs.
, that they should be at least process or structural quality indicators that are related to outcomes. To be useful at the hospital level, the indicators should be relevant for a non-negligible portion of the patients and be able to statistically distinguish between hospitals. The most interesting measures would be those that reflect medical quality by showing improved health, but from an economics point of view, measures of service quality could also be relevant if they reflect aspects of value to patients.
Several studies relate hospital costs to in-hospital or post-hospitalization mortality rates (Hussey et al., 2013) . In-hospital mortality used as the main quality indicator however poses some challenges. On the one hand, treatment costs could be low if the patient dies quickly after the admission. On the other hand, many resources are used for patients during their last days before death. This means that costs are endogenous to health outcomes, but these problems are less severe when mortality is measured regardless of death occurring in hospital or after discharge, as in this study. Alternative indicators may be based on complications (e.g., Kruse and Christensen, 2013) , which however can be quite procedure specific and hence difficult to compare across medical specialities. Readmission rates encompass aspects of both medical and service quality.
The literature suggests that there will be a U-shaped relation between costs and quality, which for higher levels of quality means that there is a trade-off between cost containment and quality improvement, while for lower levels of quality, there may be a cost-saving potential of quality improvements (Hvenegaard et al., 2009; Carey and Stefos, 2011; Gryna, 1999; Hvenegaard et al., 2011) . The intuition of the U-shaped relation would be that at lower quality levels, investments for improving quality may lower the net cost of treatment. Meanwhile, hospitals at higher levels of quality may operate on the upward sloping part where further investments may improve quality. If hospital service production is efficient, there will be a trade-off between quality and quantity or equivalently between costs and quality. All other things being equal, one cannot then increase the quality of treatment without incurring some opportunity costs such as reducing the number of patients treated or alternatively using more resources.
In empirical cross-section studies that compare hospitals, the relation will often be negative (e.g., Kruse and Christensen, 2013) . This could be because of inadequate case-mix adjustment because some patients are inherently more prone to (costly) complications and readmissions and therefore have higher expected costs. Also, if the number of cases is small, there could be a large random component in the likelihood of complications. If case-mix adjustment is adequate and the number of cases is sufficient to disregard random variations, there remains the possibility of inefficiency. If it is possible to improve quality without increasing costs or reducing quantity, then the treatment is inefficient. On a more positive note, it is possible that a hospital that provides good quality may also be good at containing costs.
In their study of cost inefficiency and mortality in Florida hospitals, Deily and McKay (2006) isolated costs due to inefficiency and found a strong association to mortality. Their study applied individual level data in a stochastic frontier analysis. In a later study including a later sample of US acute hospitals, the authors found no systematic pattern of association between cost inefficiency and hospital outcome (McKay and Deily, 2008) . Carey and Burgess (1999) found a positive relationship between costs and outpatient follow-up within 30 days after inpatient discharge for a sample of Veterans Administration (VA) hospitals in the USA. Fleming (1991) analyzed the cost and mortality/readmission relationship for Medicare beneficiaries hospitalized at 659 US hospitals and found that higher cost had a cubic association with the readmission index and surgical mortality index. Total and medical mortalities were not significantly associated with cost. Morey et al. (1992) used a national sample of 350 US hospitals to analyze the relationship between data envelopment analysis (DEA) scores and actual to predicted in-hospital deaths. They found that a reduction of one death was associated with an increase in efficient cost of $28,926. Mukamel et al. (2001) found a positive relationship between costs and risk-adjusted 30-day mortality after discharge for Medicare beneficiaries.
In a recent Canadian study, Stukel et al. (2012) found a positive association between costs and quality in a longitudinal analysis at patient level. They analyzed the association of hospital spending intensity and mortality and readmission rates for four common conditions (acute myocardial infarction (AMI), chronic heart failure, hip fracture, and colon cancer) in 129 hospitals in Ontario. This finding was confirmed by a German study, also at patient level, where they examined health outcomes (mortality at 30, 60, 90, and 365 days after discharge) for AMI as a function of costs and other patient-level variables in 318 German hospitals (Stargardt et al., 2014) . Birkmeyer et al. (2012) examined the relationships between hospital outcomes (complication rates at inpatient surgery) and risk-adjusted, 30-day episode payments for four acute and elective procedures in US hospitals. It appeared that the complication rate was positively associated with Medicare payments, indicating a negative association between costs and quality. There was no statistical significant association between costs and mortality, however.
The survey by Hussey et al. (2013) attributed the divergent conclusions on the cost-quality association partly to differences in the unit of analysis (hospital, department, or patient group), measurement of costs and quality, as well as the adapted methodology. Hospital studies were slightly more likely to report a positive association between costs and quality than studies using other levels (such as nursing homes or areas) of analysis.
Studies under the EuroHOPE project have made advances in the comparison of healthcare costs between countries and relate the costs to outcomes and quality (e.g., Iversen et al., 2015; Heijink et al., 2015) , but these studies look at a restricted set of diagnoses at a time. A recent study of the Organisation for Economic Cooperation and Development (OECD) countries analyzed the association between costs and efficiency for hospitals as a whole (Varabyova and Schreyögg, 2013) . This article aims to expand such comparisons to include the quality of care as well, measured by selected case-mix adjusted quality variables. While this study relates to the EuroHOPE project, it includes only the four major Nordic countries (Norway, Sweden, Finland, and Denmark) in the comparison because only these countries have nationwide patient registers applicable for usage of the same hospital-wide case-mix (diagnosis-related group (DRG)) system. The homogenous definition of hospital outputs used in patient registers in the Nordic countries facilitates fair comparisons across countries.
Previous studies have indicated that Finnish hospitals have significantly higher average productivity than hospitals in Sweden, Denmark, and Norway and a substantial variation within each country (Kittelsen et al., 2008; Linna et al., 2010; Medin et al., 2011; Kalseth et al., 2011) . Controlling for within-country variations in activity-based financing, length of stay (LOS), outpatient shares, university hospital status, or capital region only contributes to a small portion of these differences. This paper examines whether quality differences can form part of the explanation for productivity differences and attempts to uncover any quality-cost trade-off at the hospital level. The analysis uses both individual patient-level and hospital-level data while taking cross-country differences into account. Auxiliary aims are to evaluate the usefulness of available quality indices and the importance of case-mix adjustments in these analyses. The pooling of data from four countries has at least two advantages. Firstly, we have a much larger sample size; and secondly, we are able to identify whether our findings are due to nation-specific or structural factors.
DATA
To perform the analysis in this study, we use data on hospital input and both quantitative and qualitative outputs. The productivity analysis utilizes a single input of hospital costs and three DRG-weighted outputs (medical inpatients, surgical inpatients, and outpatient visits) based on patient-level discharge registry data from 2008 to 2009. Individually identifiable patient data were not available in Norway before 2008. To calculate 365-day mortality, demographic data have been collected also for 2010. The Danish data are affected by the strike among hospital nurses in non-acute functions in 2008. Although one might expect a productivity penalty from the strike, both DRG production and costs would be reduced, and the impact on productivity should be minor. This section describes the hospital costs and patient-level discharge data sets, their sources and definitions, as well as the quality indicators and the case-mix adjustment variables used in the analysis (more details are available in Medin et al. (2013) and Anthun et al. (2013) ). In the study, only somatic hospitals with a 24-hour emergency department or at least two medical or surgical specialities are included.
Cost data
The hospitals costs include all production-related costs from the hospitals. Costs were harmonized across the countries by excluding costs for ambulances, value added tax (VAT), capital costs, purchased care, and costs for teaching and research.
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In Sweden, the cost data were assembled mainly from the Swedish Association of Local Authorities and Regions through the cost per patient database, from hospital annual reports, and from Statistics Sweden. The hospitals not recorded in these sources were sent a cost survey. For six Swedish counties, it was not possible to create data at the hospital level; so for these counties, 2 the output was also aggregated to the county level. In Norway, the cost data were derived from the SAMDATA database of Norwegian specialized care published annually by the Directorate of Health. The National Institute for Health and Welfare in Finland collects hospital cost data annually as part of hospital productivity statistics production, while annual productivity reports published by the Ministry of Health contained the Danish cost data.
2.1.1. Cost level deflator. The collected cost data were measured in nominal prices in each country, and the costs were deflated to create real costs in each country. There were differences in currencies and input prices between the countries, and to allow for comparison between countries, the cost level had to be harmonized.
Wage indices were calculated for nine of the most important personnel groups. The wage indices were based on official wage data for the nine separate groups and included all personnel costs such as wage taxes and pension contributions Kittelsen et al., 2009; Medin et al., 2013) . Personnel costs are the most important component with about 60% of total hospital costs. For the other costs, we use the purchasing power parity-adjusted gross domestic product price index from OECD. To form the aggregate cost level deflator, the nine personnel group indices and the index for other costs were weighed with fixed Norwegian shares for 2008, as personnel shares were not available for the other countries.
Patient-level data
Patient-level data were collected from national administrative patient registries in all four countries. The level of data was departmental (speciality) discharges. Outpatient visits registered during inpatient stays were excluded.
Death outside of hospitals was collected by linking patient-level data with other registries. In Norway, this linkage is automatically carried out in the patient registry through a link with the National Population Registry. The Danish patient data were manually linked with the Population Register. In Sweden and Finland, the time to death was collected by manually linking with the cause of death registries.
2.2.1. Diagnosis-related group grouping and weights. Norway, Sweden, and Finland each have a national version of a common grouping system for the hospital visits, NordDRG, developed at the Nordic Casemix Centre.
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Denmark used to be part of NordDRG but changed to a national system DkDRG in 2002. The DkDRG system applies similar rules but is not completely comparable at the DRG level . Even though three of the countries have highly comparable systems, a common grouping is to be desired in order to enhance the comparability of the output measures and quality indices and to remove some of the idiosyncrasies inherent in each health system. All four countries have patient registers that use the same diagnosis and procedural classification systems, and Datawell Oy Finland has developed a common Nordic grouper for use in this and other projects based on definitions from the Nordic Casemix Centre. This grouper allows for similar grouper logic to be applied to all four Nordic countries. All patient-level data were regrouped in this grouper.
Common DRG weights are also needed to compare the countries. A set of cost weights were calculated from pooled 2008 and 2009 cost per patient data from Helsinki and Uusimaa hospital district in Finland grouped with the common Nordic grouper. As a robustness exercise, we have also calibrated weights for each of the Nordic DRGs using the average Swedish DRG weights of the Swedish patients assigned to that Nordic DRG. Age dummies for the groups: Agegrp1_9 0, 1-9, 10-19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80-89 Table I lists and defines the variables used in the analysis, and Table II gives descriptive statistics by country. All the indicators are binary variables at the patient level and are therefore presented as rates at the hospital or country levels. Unlike planned readmissions, emergency readmissions within 30 days of a hospital discharge (but no sooner than the next day) are commonly viewed as a signal of poor medical quality if proper case-mix adjustment has taken place (Leng et al., 1999) . Only inpatients are included in this indicator as coding practice for outpatients varies between countries. Although some level of readmissions is unavoidable, an emergency readmission could be a sign that the initial treatment was not adequate or that the discharge was premature. We include emergency readmissions for any reason, because poor quality in the initial treatment (e.g., an operation) could well cause a readmission with another diagnosis (e.g., an infection). Country differences in the readmission rates in Table II are considerable, with Denmark at less than 5% and Norway at almost 7%. In Sweden, the coverage of the variable reflecting whether the admission is acute or planned is bad. As a substitute, we also included an indicator for all readmissions as an inpatient, regardless of emergency status. This is clearly more difficult to interpret as a sign of quality, as planned readmissions may be valid parts of a hospital treatment episode. However, in many cases, it will have a service quality dimension, because going in and out of hospitals is usually not appreciated by patients. Table II reveals that there is substantial variation in inpatient readmission patterns between countries. Mortality rates 4 are the most widely accepted quality indicators. Even though some of the mortalities are unavoidable, lowering mortality is always an improvement. It has the additional advantage of being coded with little possibility of error. We have included four variants with different time perspectives, death within 30, 90, 180, and 365 days. There is a possibility of a person having several hospital stays within the last days of life, so the differential readmission patterns between countries would influence this indicator if the mortality was attributed fully to all hospital stays. We have therefore calculated a mortality dummy only if the stay is the last in the data before death, in order to attribute the death to this particular admission. In order to calculate 365-day mortality, we have collected patient data for the two years 2008 and 2009, and deaths also for 2010.
Patient safety indices (PSIs) are based on OECD standards using secondary diagnoses (Drösler, 2008) . Most of these are applicable only to special patient groups, and Table II reveals very small raw rates, almost all less than a 10th of a percent. These also vary considerably between countries, with the Finnish numbers particularly low. The PSIs are based on secondary diagnoses, and we are aware of large differences in coding practices between countries. Secondary diagnoses are rarely reported in Finland, and the rate of PSIs is closely correlated with the reporting of secondary diagnoses (OECD, 2009 ). Thus, we cannot determine how much of the variation between countries is due to differences in quality and how much to coding, but within-country comparisons may still be valid.
Several other PSI definitions are available but could not be calculated from the available patient registers. Two more PSIs were initially included but turned out to be so infrequent that case-mix adjustments and hospital differences were meaningless. Numerous other quality indicators have been suggested and discarded, most because data were not available for several countries. In many cases, the data available for these indicators were not reliable. Time from referral to admission ('waiting time') could not be included because the definitions of referral date differed across countries and were not available at all for Sweden. Similarly, the time from admission to first procedure ('lead time within hospital') was not registered in Denmark and Sweden.
2.2.3. Case-mix adjusting variables. For the case-mix adjustment procedure, we have used most of the variables available in the patient registers. Ideally, the adjusting variables should capture characteristics of the patients and their illnesses that possibly influence the outcome, whatever the treatment given by the hospital. The primary risk adjustor used is the DRG formed with the common Nordic grouper. Because the division into the more than 700 DRGs is designed to capture most measurable patient differences that may influence costs, they will also capture many of the aspects that influence the expected values of the quality indicators.
The group of patient characteristics shown in Tables I and II comprises gender and age in 10-year groups, with a special infant group of less than 1 year. For data privacy reasons, the precise age was not available in the pooled cross-country dataset. Although partly endogenous, treatment variables are also allowed to adjust for risk, because these may reflect severity. The variables we coded for describing patient transfers in and out of hospital or department (where patient came from and where they went) do not distinguish between transfer to/from home, a (non-hospital) health clinic, or a nursing home as we had to use information available in all four countries. Comorbidity is included both as the number of secondary diagnoses and as the Charlson comorbidity index, which in turn is based on information from secondary diagnoses (Charlson et al., 1987) . LOS may reflect inefficiency in addition to severity (or even quality). LOS is also an endogenous variable to the hospital.
We have also included some characteristics for the patients' residence municipality in order to capture some socioeconomic differences. These variables are, however, not without challenges. Firstly, they are likely to be dependent between patients in each hospital, because most patients come from a limited number of municipalities in the hospital catchment area. In addition, they may to a large extent capture country effects, because there are marked differences between, for example, unemployment levels following the financial crisis. Finally, we have included travel time between the center of the residence municipality of each patient and the hospital, 5 a variable that previously has shown some explanatory power on hospital costs and that may have some also on quality outcomes (Kalseth et al., 2011) .
METHODS

Case-mix adjustments
For the case-mix adjusted hospital performance measures, we follow Ash et al. (2003) and calculate the observed-to-expected ratio of each quality indicator for each hospital. The expected value, and thus the performance measure, is estimated in each of the six different models m ∈ (0, … ,5).
Each patient i has an (binary) observable quality indicator, ω ihk , and an expected quality indicator,ω m ihk , subscripted by hospital h ∈ (1, … ,H) and DRG k ∈ (1, …, K). We suppress an index for which indicator we are studying (see Table I for a list of all quality indicators).
The case-mix adjusted hospital performance measures, P m h , are calculated by summing all observed patient outcomes and dividing by the sum of all expected patient outcomes
where P m h is the performance indicator for hospital h in model m ∈ (0, … ,5) and N hk is the number of patients in DRG k at hospital h. Because all our quality indicators are such that a lower number implies better quality, so will a lower value for the performance measure, P m h . The performance measures P m h for m ∈ (0, … ,5) differ in the way we predictω m ihk . In our simplest model, m = 0, we exploit that each hospital has a different composition of DRGs. The predicted quality indicator for patient i,ω 0 ihk , is thus just the average value of the quality indicator within each DRG for all patients across all hospitals. The predicted outcomes of this model can be written aŝ
which is independent of i and h and thus equal for all patients in DRG k. The predicted quality measure,ω 2013). However, given the large number of observations, we need not assume that the explanatory variables have the same impact in all DRGs. Rather, for each DRG k, we calculate the expected value as the predicted value based on the maximum likelihood estimation of
where ω m ihk is the quality measure for patient i in DRG k at hospital h; the coefficient vectors β m 0k ; β m k are specific to each DRG k and model m ∈ (1 … 5); z m ihk is a vector of individual case-mix adjusting variables; and ε m ihk is the error term, which is assumed to be normally distributed.
For each of the K DRGs and 11 indicators, we estimate five different models m, where higher-order models include more explanatory variables z (confer Table I for all case-mix adjusting variables). In model 1, the explanatory variables captured by z are the patient characteristics; in model 2, the vector includes both patient characteristics and the treatment variables; in model 3, the LOS is also added; model 4 includes also municipal characteristics for the patients' resident municipality; while model 5 adds the traveling time between the resident municipality and the treating hospital. The patients' predicted quality measures,ω m ihk , are calculated by setting the error term in Equation (3) to zero.
Following Moger and Peltola (2014) , there are no hospital dummies in the estimation of Equation (3 
À
Á 2 to indicate the share of explained variance. Finally, we calculate and report the area under the curve (AUC) from receiver operating characteristic analysis. The AUC is commonly used for evaluating the ability of predictions from a logistic regression model in discriminating between outcomes and can be interpreted as the probability that, for example, the fatality prediction for a randomly selected patient who died is greater than the fatality prediction for a surviving patient.
Productivity estimates
The productivity estimates for the hospitals are based on Farrell (1957) who defined (the input oriented) technical efficiency as
where (x i , y i ) is the input/output vector for an observation i and T is the technology or production possibility, usually assumed to be specific to year and country. For an input/output vector (x, y) to be part of the production possibility set, we need to be able to produce y using x. Efficiency is then the minimal proportionality factor θ on inputs that is consistent with feasibility, that is, what proportion of inputs are necessary to produce the given output vector.
Estimates of efficiency rely on estimates for the specific technology T; but for comparing productivities, only a common reference surface for observations is needed. The literature on Malmquist productivity indices uses an (homogenous in inputs and outputs) envelopment of the technology to estimate changes in technical productivity over time (Førsund and Hjalmarsson, 1987; Grifell-Tatjé and Lovell, 1995) . To compare the productivity of two or more observations, we do not need to estimate the separate country-specific and timespecific technologies but may instead rely on an estimate of the meta-frontier or the envelopment of the underlying technologies (Asmild and Tam, 2007) . Productivity estimates of individual observations are then compared with this global measure of the highest attainable productivity. Here, we will estimate productivity of a hospital by calculating the reference set T from the pooled set of all hospitals across the Nordic countries and the two years 2008 and 2009 and then comparing individual hospitals to the reference set.
The estimates of the reference set, and therefore of the productivity of each hospital observation, are made using the homogenous version of the non-parametric DEA, one of the two main methods in the productivity literature (Coelli et al., 2005; Fried et al., 2008 ). This does not imply an assumption of constant returns to scale technology, because the reference frontier is only a homogenous envelopment of the underlying technology.
7 Because DEA estimates are known to be biased and the statistical properties are not available in closed form, bias-corrected estimates and confidence intervals have been calculated using the bootstrapping algorithm from Simar and Wilson (1998) . The average cost per DRG point, which does not use a frontier method, is also calculated.
Productivity-quality trade-off
This article offers no full behavioral model of the relationship between productivity and quality. We start by calculating the hospital level pairwise Pearson correlation coefficient for each performance indicator, average costs (operating costs/DRG points), and productivity estimates. Additionally, we estimate a simple regression model with random hospital effects, assuming that the unobserved hospital heterogeneity is uncorrelated with the included variables (Greene, 2000) 8
whereTP hct is the DEA bootstrapped estimate of productivity for hospital h in country c in year t andP ht is a vector of the performance indicators estimated in model 2 ( Table V) . Note that for estimating the productivityquality trade-off, we have calculated two performance measures for each hospital, one for each year, instead of pooling both years in a single hospital performance measure. x hct is a vector of hospital-specific variables, including municipal variables averaged at the hospital level (Table VI) ; and λ c contains country fixed effects. Equation (5) is also estimated for each country separately thus leaving out the country-specific fixed effects.
RESULTS
Case-mix adjustments
Summarizing the more than 700 case-mix adjustment logit regressions for each of the 11 quality indicators is not straightforward. The R-squared statistics (shown in Table A .I of the Appendix) is rather low for all models. This is common in logistic regressions as the outcomes are 0 or 1, while the predictions are almost always between. Because of the large number of observations, R-squared for all models are significantly larger than zero; and for every quality indicator, adding a block of variables significantly increases the share of explained variance. 9 This test therefore gives no direct guidance on the model specification. We note, however, that the DRGs in model 0 explain at most 9% of the variance of the quality indicators. Adding patient characteristics as is performed in model 1 does not change this pattern and hardly adds any explanatory power. Adding the treatment variables in model 2 and LOS in model 3 increases R-squared somewhat for readmission rates, mortality rates, and for PSI13 (sepsis). The municipal and travel time variables of models 4 and 5, respectively, only slightly increase R-squared. The normalized Pearson goodness-of-fit test (shown in Table A .II of the Appendix) fails to reject the large majority of models. Model 1 is rejected for some of the quality indices and for PSI18 (Obstetric trauma) also, model 2 is rejected; but here, it seems that the problem is that PSI18 only applies to women in specific DRGs and age groups.
More interesting are probably the AUC results shown in Table III. 10 The ability to discriminate between outcomes is very high for all mortality and PSI indicators. For the mortality indicators, the inclusion of patient characteristics significantly increases the AUC estimates and weakly so does the inclusion of treatment variables. For the PSIs, patient characteristics do not seem to matter but treatment variables do. LOS, municipal variables, and travel time do not contribute for these quality indicators. The readmission variables have a clearly different pattern, with lower but considerable AUCs in all models. Here, the inclusion of patient characteristics and treatment variables is significant, as well as the municipal variables. It must be noted, however, that there are large country differences in some of the municipal variables, for example, the number of foreign citizens and the unemployment rates in the wake of the financial crisis.
The statistical evidence seems to favor model 2, with some exceptions. The purpose of these models is to level the field in country and hospital comparisons. The choice of case-mix adjustment model specification must therefore also take account of the problems of country effects in the municipal variables. In addition, the LOS is to a large extent an endogenous variable for the hospital in question and may be more of a mediating than confounding variable. In the further analysis, we therefore use model 2, that is, the model without LOS, the municipal variables, and travel time, returning to these only in the hospital trade-off regressions. 
Country and hospital differences
The case-mix adjustments (in model 2) change the relative performance of the countries to some extent. Table IV gives the mean performance measure at the country level, with a 99% confidence interval calculated from the individual patients' predicted values. By construction, each performance measure has a mean of 1.0 when averaging over all four Nordic countries, rendering almost all country-specific performance measures significantly different from the Nordic mean. As the quality measures used are by definition 'measures of low quality', lower performance measures denote higher quality. The quality measures in Table IV do not give a uniform picture of the quality of care in any of the Nordic countries. Neither do they indicate any clear ranking of the countries. While Denmark has clearly fewer emergency readmissions, Norway has the lowest mortality rates. The inpatient readmission rates, on the other hand, are higher in Norway and Finland than in Denmark and Sweden. PSI12 (pulmonary/deep vein thrombosis) and PSI13 (sepsis) are the lowest for Norway; PSI15 (accidental cut, puncture, or haemorrhage during medical care) is the lowest in Denmark; while Finland has the lowest score for PSI18 (obstetric trauma) and bed sores. Table V shows the percentage of hospitals across both years with performance measures significantly different from the Nordic mean of 1. This holds for almost all of the readmission variables, and for a large majority of the mortality rates, but to a lesser and mixed extent for the PSIs. For readmission variables, Denmark and Finland have the largest shares of hospitals with performance measures different from the Nordic mean. Sweden has the largest share of hospitals with significantly different means in two mortality measures. For mortality within 30 days, Norway has the largest share of hospitals with significantly different means. The last column of Table V shows the significance of the hospitals in explaining the variation remaining after the case-mix adjustment of model 2, based on a linear ANOVA test of the difference between observed and predicted values (Greene, 2000) . The results show that hospitals are significantly different from each other in their performance measures for all quality indicators. Given the very large number of patient observations, the F-values are not particularly high for the mortality indicators and definitely weak for the PSIs. Figure 1 plots four of the performance measures and their 99% confidence intervals for the individual hospitals sorted by countries. For emergency readmissions (panel a), the confidence intervals are very narrow, which means that there are significant differences between most hospitals. There is mostly a clear ranking of hospitals within countries, because each hospital performance measure is mainly outside the range of other hospitals' confidence intervals. As noted, Denmark has the lowest emergency readmission rates, but there is For 30-day or 365-day mortality, the confidence intervals are wider, but most hospitals are still significantly different from the mean and from each other. Most Norwegian hospitals have significantly lower 30-day mortality than hospitals in the other countries, but these differences are less marked when comparing 365-day mortality (panels c and d, respectively).
Productivity
To look into the possible trade-off between hospital productivity and quality, we first had to estimate hospital productivity. As noted in 2.2., we here use a common Nordic version of the NordDRG grouper, which makes it possible to compile hospital output measures that are comparable between countries. Figure 2 shows the bias-corrected DEA productivity estimates of the hospitals sorted by country and productivity levels, with the width of the bars proportionate to hospital costs. Bootstrapped 95% confidence intervals are also shown.
The figure confirms the previous results that Finnish hospitals are on average more productive than in the other Nordic countries, even though Denmark is almost as productive (Medin et al., 2011; Kittelsen et al., 2008; Linna et al., 2010; Kittelsen et al., 2015) . Even Norway has not much of a cost disadvantage in this analysis, a clear catching up from previous studies. Sweden, however, still lags behind. As a first robustness test, average costs (real costs per DRG point) have also been calculated and show essentially the same picture with a correlation of À88.6%. We have also recalculated the DRG points using calibrated Swedish DRG weights and results are again very similar, with a correlation between productivity estimates of 90.2%. Table A .III in the Appendix shows the mean hospital inputs, outputs, and productivity estimates for each country.
Productivity-quality trade-off
When productivity estimates are plotted against four of the performance measures in Figure 3 , one finds no strong correlations. In all panels, the optimal frontier would be at the lower right with the highest productivity and the lowest performance measure, keeping in mind that a low performance measure indicates higher quality. In panel a, there is a slightly negative correlation (r = À0.155) between productivity and emergency readmissions, implying no trade-off between high quality and high productivity. There is a slight tendency for low emergency readmission rates to go together with high productivity in Finland, but the main impression is a large dispersion. Panel b shows some positive correlation, implying that having high productivity goes together with high number of inpatient readmissions. There seems to be a trade-off between quality and productivity but only in so far as the inpatient readmission rate is a valid quality indicator.
For the two mortality rates shown in Figure 3 , mortality within 30 days and mortality within 365 days of hospital episode, there is a clear negative correlation between productivity and performance measures, which is strongest for 365-day mortality. This would imply that there is no trade-off between productivity and quality, and it is possible to improve both productivity and quality at the same time.
The pairwise correlations between measures of productivity and quality in Figure 3 are reported in the first column of Table VI, which draws on the full correlation matrix in Table A .IV in the Appendix. Standard errors in (). Significant coefficients are marked at * 0.10; ** 0.05; *** 0.01 level. Hausman tests reject random effects for model I (XThe next columns of Table VI show the results of the random effects regressions on the bias-corrected productivity estimate with the main performance measures at the hospital level as explanatory variables (Equation (5)). For reasons of collinearity, only one mortality measure, mortality within 30 days, is included. The results for the PSIs are also deemed too weak to be valid as measures of quality for hospitals as a whole and therefore not included as explanatory variables. Column I excludes the emergency readmissions, because Sweden has no observations on this measure, while column II instead excludes the Swedish observations. The last four columns show regressions for each country separately. The country-specific models have generally less explanatory power due to the low number of observations. The negative pairwise correlation between productivity and emergency readmissions disappears when modeled simultaneously with the other performance measures and the control variables. Looking at individual countries, only in Finland is there a significant negative coefficient, indicating no trade-off between productivity and emergency readmission rates. In Denmark and Norway, the coefficients are positive but insignificant. The lack of significance in some of the country-specific associations may partly reflect the low number of observations. For inpatient readmission, the positive correlation, indicating a trade-off, carries through to the regression coefficients, with high inpatient readmission rates being associated with high productivity, particularly in Finland and Norway.
As in Figure 3 , there seems to be some association of high quality and high productivity when using 30-day mortality as a quality measure on a pooled dataset with all countries. However, in the countryspecific regressions, the association is only significant for Denmark.
Of the controls, Sweden has significantly lower productivity, while the Norway and Denmark dummies are not significant. In common with previous studies (Kalseth et al., 2011) , one finds a negative association between productivity and the traveling time, which seems to be influenced mainly by the Norwegian observations. No other controls are significant.
DISCUSSION
Our study confirms the productivity differences from previous studies with a similar ranking of the countries where Finnish hospitals have the highest productivity estimates followed by Denmark and Norway and last Sweden. Overall, there is a weak pattern that Norway and Denmark show higher performance in quality and Sweden lower performance; thus, there is no trade-off between productivity and quality at the country level. The distance between hospitals in Sweden and the other countries is even larger when taking quality aspects into account, although the confidence intervals for several indicators are overlapping, which makes ranking of hospitals within each country difficult.
Case-mix adjustment of quality indicators is important; and in some cases, the ranking of countries changed as a result of the adjustment. Our result shows that there are major and significant differences in the included case-mix adjusted quality indicators, especially across countries. One example is inpatient readmission within 30 days where Denmark has less than half compared with the other countries. Also, mortality within 30 days after last admittance varies considerably with Norway having the lowest rates and Finland the highest. The ranking of the countries changes for the longer periods up to 365 days after admission, where Finland has lower mortality rates than both Sweden and Denmark. The case-mix adjusted performance measures for hospitals show larger differences for readmissions than for mortality after last admission. The smaller variation for mortality is in line with other studies about mortality differences. In Sweden and Norway, 30-day mortality of AMI was lower than that in Finland; but for stroke and hip fracture, there was no difference between the three countries (Heijink et al., 2015; Häkkinen et al., 2015; Hagen et al., 2015; Medin et al., 2015; Peltola et al., 2015) . Other quality indicators largely confirm these country level differences and are based on a low frequency of events, and some PSIs are not usable for quality comparisons at the country level because of poor or divergent coding. PSIs may still reveal important differences between and within countries with lower general standard of health care, such as in some developing countries. For most quality indicators, the performance measures reveal room for improvement in Nordic hospitals.
The hospital variables do not contribute to the explanation of the differences in productivity. The number of patients, as a proxy for size, is not significant nor is university hospitals or capital city. A number of municipal variables were tested, and only travel time was associated with higher costs and then only in Norway.
Regarding the cost-quality trade-off, there is a statistical significant negative relationship between hospital-level productivity and mortality within 30 days. Assuming that the case-mix adjustment is adequate, the driving mechanism seems to be that treating dying patients is costly for the hospitals, and the efficient hospitals are those that are better at preventing mortality. This relationship is valid for all countries, but in the analysis for each country, it is only significant for Denmark. Hospitals with higher inpatient readmissions within 30 days have a tendency for also having higher productivity. This relationship is significant for Finland and Norway indicating a productivity-quality tradeoff.
The conclusion from the review by Hussey et al. (2013) was that evidence of the direct association between productivity and quality is inconsistent but that the association is small to moderate. Of these, six studies used similar outcome indicators as in our study (Barnato et al., 2010; Bradbury et al., 1994; Carey and Burgess, 1999; Deily and McKay 2006; McKay and Deily, 2008; Fleming, 1991) . Among these studies, three indicate a clear negative relationship. Compared with our study, these studies include several limitations. Outcome is often measured using in-hospital mortality, or data are restricted to Medicare patients (over 65). In addition, the cost measures in the US studies usually exclude the costs for the physician, whereas in our study, the wages of physicians are included.
In some of the recent studies referenced in the introduction, the outcome measures are similar to the present study. Stukel et al. (2012) found that higher hospital spending intensity was associated with better survival and lower admission rates. Stargardt et al. (2014) confirmed the trade-off between costs and outcomes, estimating that an increase of costs by €100 leads to a reduction in mortality risk by 0.4%. Doyle et al. (2015) also found that patients brought to a higher cost hospital have lower mortality. These studies show a different result to ours by finding a productivity-quality trade-off. The US study at hospital level by Birkmeyer et al. (2012) came to a somewhat different conclusion. The study found a strong positive correlation between complication rates and episode payments, indicating that efforts to improve surgical quality may reduce costs. This study differed in the cost estimation as the time window was extended to 30 days after discharge, which could explain a different correlation pattern where low quality leads to high costs after discharge.
Controlling sufficiently for patient-case mix is a major concern and may be a limitation of our study. The most important variables included are the DRGs formed with the common Nordic grouper, age, gender, hospital transfers, and comorbidities. Still, as coding practices differ across the countries (especially in the reporting of secondary diagnoses), true differences in risk factors at the patient level may not be sufficiently captured. There is a need for improvement in harmonization in coding across countries.
The use of average cost to weigh the patient discharges in different DRGs does not necessarily reflect the social willingness to pay for the different treatment groups. Basing these weights on average costs in two Finnish municipalities poses additional problems if these weights then reflect costs or incentives that are particular for Finland. However, using calibrated Swedish weights showed results to be quite robust, and previous studies that exploit the variation in the use of activity-based financing in Nordic hospitals have found little effect on productivity (Kittelsen et al., 2008) . Still, there is a clear need for further research on the effect of different weight sets for the measurement of productivity.
Another limitation of this study is that health outcomes and productivity measures are reported at the hospital level, which may conceal differences in outcomes across medical conditions. In a recent European study , the results indicated that there was no correlation either at the national or at the hospital level, between the quality in treatment of two different acute conditions (stroke and AMI). The results indicate that the quality of treatment for one specific health problem (disease) cannot be used as a proxy for hospital level overall quality of care.
Finland treats patients with incurable diseases to a larger extent outside acute hospitals, which may have an impact on hospital mortality figures. Still this does not explain the differences in-hospital mortality between Norway and Sweden, and some of these effects may have been controlled for by the use of age groups in the case-mix adjustments.
Finally, it is an important limitation that causal inferences cannot be drawn from the regressions; instead, these indicate the strength of statistical associations. In particular, the productivity-quality trade-off regressions are not set in a behavioral model with adequately specified econometric structure.
CONCLUSION
The results show that there are significant differences between countries on most measured quality indicators. Case-mix adjustments are necessary but explain only a minor portion of quality variation. There are significant differences also between hospitals within countries, but only the readmission and mortality measures show enough differences to rank the majority of hospitals. For PSIs, the confidence intervals overlap too much for rankings to be meaningful. The PSI events are too infrequent in the Nordic countries to discriminate between chance and true hospital or country differences, and are generally prone to be invalid for country comparisons due to differences in coding practices. This highlights the need for continuous improvements in the harmonization of coding systems and patient registry information. At this point in time, only some patient registry-based quality indicators are useable for international comparisons, especially if one looks beyond the Nordic countries. If individual hospital managers are to learn from other hospitals, and national policy makers are to learn from other countries, comparable data must be provided. This does not necessarily imply use of common DRG systems or incentives but that the underlying diagnosis, procedure, and case-mix adjustment codes have the same content.
While previous findings on the relative productivity of the hospitals in the Nordic countries are confirmed, there is no clear pattern that any country has higher or lower quality on all measures. This may be due to the limitations of the available data as discussed earlier. This may also be due to that the treatment patterns and practices vary a lot between countries, even for countries that are as similar as Denmark, Finland, Norway, and Sweden. This is consistent with previous findings that efficiencies are similar across countries but that there are country-specific factors that make the production possibilities significantly different . Unfortunately, statistical methods have difficulty in identifying the effect of country-specific factors with only four countries. Again, the use of data from countries outside the Nordic region could give a better foundation for general results.
The evidence for a trade-off or a positive association between quality and productivity varies between the different performance measures. There seems to be a trade-off between productivity and better (lower) inpatient readmission rates, but high productivity is associated with lower mortality rates. Policies aimed at reducing readmission rates may be costly. There may be differences between emergency and planned readmissions in this regard, but it is important to look into how incentives for readmissions vary between countries. Policies aimed at decreasing mortality rates may reduce costs and increase productivity at the hospital level. For mortality at least, there seems to be a possibility of improving both quality and productivity. Model m includes all variables from model m-1. R 2 estimates for model m that are significantly higher than that of model m-1 are marked at * 0.10; ** 0.05; *** 0.01 level. Calculations have been performed using Stata 13 matrix commands. There are 58 158 847 observations except for Readm30_Emergency which is not registered in Sweden and therefore has only 39 274 414 observations. 
